Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACER
12976
PUT
DELISTED
Acer Therapeutics Inc
ACER
| $20.1K | ﹤0.01% |
26,500
+22,900
| +636% | +$45.2K |
|
|
LVOX
12977
PUT
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $20.1K | ﹤0.01% |
6,500
-34,700
| -84% | -$92.1K |
|
|
NBRV
12978
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $20.1K | ﹤0.01% |
+11,607
| New | +$19.5K |
|
|
FABC
12979
Fabric.AI Inc
FABC
$18.8M
| $20.1K | ﹤0.01% |
285
-99
| -26% | -$7.96K |
|
12980
CALL
Aquestive Therapeutics
AQST
$533M
| $20.1K | ﹤0.01% |
17,600
-32,600
| -65% | -$28.3K |
|
12981
PUT
Scholar Rock
SRRK
$6.4B
| $20K | ﹤0.01% |
2,500
+1,100
| +79% | +$11.2K |
|
12982
PUT
Lightbridge
LTBR
$317M
| $20K | ﹤0.01% |
4,900
-9,500
| -66% | -$39.7K |
|
|
OIG
12983
CALL
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $20K | ﹤0.01% |
3,423
+370
| +12% | +$2.47K |
|
12984
AEye
LIDR
$60.9M
| $19.9K | ﹤0.01% |
2,111
-825
| -28% | -$14.2K |
|
12985
Greenpro Capital
GRNQ
$13.9M
| $19.9K | ﹤0.01% |
1,337
-4,773
| -78% | -$67.2K |
|
12986
CLPS Inc
CLPS
$25.8M
| $19.9K | ﹤0.01% |
17,456
-4,093
| -19% | -$5.55K |
|
12987
CALL
US Global Investors
GROW
$39.4M
| $19.8K | ﹤0.01% |
7,500
-6,200
| -45% | -$17.9K |
|
|
SIFY
12988
CALL
Sify Technologies
SIFY
$1.13B
| $19.8K | ﹤0.01% |
2,617
+1,767
| +208% | +$16.6K |
|
12989
PUT
Artivion
AORT
$1.42B
| $19.6K | ﹤0.01% |
1,500
+1,000
| +200% | +$12.8K |
|
|
SAIH
12990
SAIHEAT Ltd
SAIH
$36.2M
| $19.6K | ﹤0.01% |
1,065
-6,862
| -87% | -$138K |
|
12991
Powell Industries
POWL
$7.78B
| $19.6K | ﹤0.01% |
1,380
-149,727
| -99% | -$2.07M |
|
12992
vTv Therapeutics
VTVT
$119M
| $19.6K | ﹤0.01% |
606
-616
| -50% | -$20.9K |
|
|
JBGS
12993
PUT
JBG SMITH
JBGS
$672M
| $19.6K | ﹤0.01% |
1,300
-900
| -41% | -$16K |
|
|
CTG
12994
PUT
DELISTED
Computer Task Group, Inc.
CTG
| $19.6K | ﹤0.01% |
2,700
+2,400
| +800% | +$17.7K |
|
|
HARP
12995
CALL
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $19.6K | ﹤0.01% |
2,630
+920
| +54% | +$7.74K |
|
12996
CALL
ARKO Corp
ARKO
$544M
| $19.5K | ﹤0.01% |
2,300
+1,900
| +475% | +$15.8K |
|
12997
CALL
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $19.5K | ﹤0.01% |
400
-52,400
| -99% | -$2.52M |
|
12998
PUT
ProShares Short S&P500
SH
$841M
| $19.5K | ﹤0.01% |
325
-10,850
| -97% | -$670K |
|
12999
HF Foods Group
HFFG
$99.2M
| $19.5K | ﹤0.01% |
+4,966
| New | +$20.7K |
|
13000
PUT
ESS Tech
GWH
$20.4M
| $19.5K | ﹤0.01% |
933
-1,227
| -57% | -$34.2K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.